CDC141: A Protein with Potent Therapeutic Potential (G285025)

Target Name: CCDC141

NCBI ID: G285025

CCDC141

CDC141: A Protein with Potent Therapeutic Potential

CCDC141 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the superfamily of COX-2-like proteins, which are involved in cellular signaling and inflammation.

One of the unique features of CCDC141 is its ability to induce cell death, either through apoptosis or necroptosis. This property makes it a potential drug target, as researchers are interested in finding ways to inhibit CCDC141's ability to cause cell death.

CDC141 has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of CCDC141 are associated with increased risk of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, CCDC141 has also been shown to be a potential biomarker for certain diseases. For example, studies have shown that CCDC141 is downregulated in the brains of individuals with Alzheimer's disease, and that this downregulation is associated with increased risk of disease.

Another promising aspect of CCDC141 is its ability to modulate the activity of other proteins, including COX-2, which is a well-established drug target for pain and inflammation. This suggests that CCDC141 may have additional functions beyond its role as a protein that induces cell death.

In conclusion, CCDC141 is a protein that has intriguing properties and is being studied as a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular signaling and disease, and to develop effective therapies that target CCDC141.

Protein Name: Coiled-coil Domain Containing 141

Functions: Plays a critical role in radial migration and centrosomal function

The "CCDC141 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC141 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets